Product Information
POTASSIUM CITRATE ER 10 MEQ TB is a generic product labeled by BioComp Pharma Inc., priced at $0.1813 per EA under NDC 44523041001. Its NADAC has been published 64 times since Apr 9, 2025.
Strength
10 meq/1
Manufacturer
BioComp Pharma Inc.NDC
44523041001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019071On Market Since
12/3/2024
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 10 MEQ TB has been published 64 times since Apr 9, 2025, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1813 per EA |
|---|---|
| All-time high | $0.2321 (May 14, 2025) |
| All-time low | $0.1666 (Sep 17, 2025) |
| 52-week high | $0.2180 |
| 52-week low | $0.1666 |
| Median price | $0.1785 |
| Average price | $0.1877 |
| Largest weekly change | -10.5% (Jul 23, 2025) |
| Weeks tracked | 64 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 10 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 10 MEQ TB, manufactured by BioComp Pharma Inc., is $0.1813 per EA (NDC 44523041001), effective Jun 24, 2026.
How has the price of POTASSIUM CITRATE ER 10 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has declined 20.8%. It has been tracked across 64 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 10 MEQ TB?
Since Apr 9, 2025, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has ranged from a low of $0.1666 (Sep 17, 2025) to a high of $0.2321 (May 14, 2025), with a median of $0.1785 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 10 MEQ TB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as POTASSIUM CITRATE ER 10 MEQ TB, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 10 MEQ TB?
POTASSIUM CITRATE ER 10 MEQ TB (NDC 44523041001) is labeled by BioComp Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification